ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Total Non-Current Liabilities of $815857.0 for Q1 2026, down 4.23% YoY from $851928.0 in Q1 2025, and down 3.19% sequentially from $842721.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $815857.0 for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 4.23% year-over-year to $815857.0; the TTM figure through Mar 2026 stood at $815857.0 (down 4.23% YoY), while the FY2025 annual figure was $842721.0, down 34.51% from the prior year.
- Total Non-Current Liabilities declined to $815857.0 in Q1 2026, from $842721.0 in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for NDRA reached as high as $1.3 million in Q4 2024 and fell as low as $98421.0 in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $786870.5 (2025), against an average of $628945.5.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities plunged 47.51% — and 2025, when it soared 670.04%.
- A 5-year view of Total Non-Current Liabilities shows it stood at $365919.0 in 2022, then sank by 47.51% to $192062.0 in 2023, then jumped by 569.97% to $1.3 million in 2024, then slumped by 34.51% to $842721.0 in 2025, then dropped by 3.19% to $815857.0 in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $815857.0, $842721.0, and $992421.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.45 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.42 Bn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | 815,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 815,857.00 |
| Dec 31, 2025 | 842,721.00 |
| Sep 30, 2025 | 992,421.00 |
| Jun 30, 2025 | 757,884.00 |
| Mar 31, 2025 | 851,928.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 960,379.00 |
| Jun 30, 2024 | 98,421.00 |
| Mar 31, 2024 | 145,825.00 |
| Dec 31, 2023 | 192,062.00 |
| Sep 30, 2023 | 237,163.00 |
| Dec 31, 2022 | 365,919.00 |
| Mar 31, 2021 | 280,829.00 |
| Dec 31, 2020 | 608,992.00 |
| Sep 30, 2020 | 627,573.00 |
| Jun 30, 2020 | 645,450.00 |
| Mar 31, 2020 | 325,804.00 |
| Dec 31, 2019 | 342,812.00 |
| Sep 30, 2019 | 358,915.00 |